StonvexLoading…
StonvexCore line items from PRVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $603.85M | $2.12B | $1.58B | $1.00B |
Operating Income | $7.42M | $34.23M | $22.96M | $8.55M |
Net Income | $3.06M | $22.92M | $13.77M | $6.91M |
EPS (Diluted) | $0.02 | $0.18 | $0.11 | $0.05 |
Total Assets | $1.42B | $1.37B | $1.35B | $1.27B |
Total Liabilities | $611.99M | $578.43M | $588.23M | $539.00M |
Cash & Equivalents | $419.52M | $479.69M | $441.35M | $390.13M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 125.69M | 123.60M | 122.87M | 122.67M |